siRNA are double-stranded RNA molecules that offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production.
News
Venclexta/Venclyxto combo extends myeloid leukaemia survival
Roche also reported that safety for Venclexta/Venclyxto with azacitidine appeared consistent with the known safety profile of these medicines.
COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli Lilly halts trial enrolment
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 6,650, with 335 deaths and 135 recoveries.
COVID-19: NIHR awards £10.5m to six new projects as NHS receives more protective equipment
One of the projects will investigate potential vaccines, and could begin as early as June.
Five-year Zolgensma data shows SMA benefit
If left untreated, SMA type I leads to death or the need for permanent ventilation by the age of two in more than 90% of cases.
COVID-19: UK clinical tests to start next month as global authorities see spike in unauthorised meds
According to Interpol, the seizures represent “only the tip of the iceberg”, as surgical masks were also named as the counterfeit medical device most commonly sold online.
FDA dismisses Jardiance for type I diabetes
The decision follows an FDA panel vote last November recommending against the approval of the drug.
NHS enters major deal to expand hospital capacity, including 8,000 beds
The independent sector will also reallocate practically its entire national hospital capacity to the NHS.
ViiV sees first global approval of Cabenuva in Canada
Canada has also approved Vocabria to be used for short time periods in conjunction with the drug.
COVID-19: CMA, NIHR, AbbVie updates
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 3,269, with 144 deaths and 65 recoveries.
£27 million pledged to fight “world’s biggest killers”
The company will be able to accelerate the development of an innovative drug and technology pipeline, born from The George Institute’s research program.
FDA OKs Gilead’s paediatric hep C drug
Epclusa is the first pan-genotypic, protease inhibitor-free regimen approved in the United States for adults and children.
Ex-NHS workers told “Your NHS Needs You”
The recruitment drive is aimed at more than 65,000 former nurses and doctors.
COVID-19: Roche starts clinical trial as UK cases continue to rise
The current recorded case count for COVID-19 (coronavirus) in the UK has hit 2,626, with 104 deaths and 65 recoveries.
NHS data shows gap in care for heart failure patients
Potentially a third of people with heart failure are not being screened for iron deficiency and iron deficiency anaemia, with potentially debilitating effects on their quality of life.
